Security key
22978P106
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 18,582,224
- Share change
- -232,686
- Total reported value
- $216,368,968
- Put/Call ratio
- 254%
- Price per share
- $11.65
- Number of holders
- 89
- Value change
- -$2,774,327
- Number of buys
- 40
- Number of sells
- 41
Report period
Q2 2021
Institutions
89
Top holders
10
CUE full security history
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Cue Biopharma, Inc. SEC filings
Cue Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22978P106
Recent filing periods:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13F
|
Company |
6.2%
|
2,703,983
|
$32,989,000 | — | 31 Mar 2021 | |
| Corriente Advisors, LLC |
13F
|
Company |
5.9%
|
2,549,031
|
$31,098,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.2%
|
2,247,704
|
$27,422,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
1,554,450
|
$18,965,000 | — | 31 Mar 2021 | |
| Slate Path Capital LP |
13F
|
Company |
3.4%
|
1,483,619
|
$18,100,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
1,370,605
|
$16,721,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
602,094
|
$7,346,000 | — | 31 Mar 2021 | |
| Prosight Management, LP |
13F
|
Company |
1.3%
|
556,777
|
$6,793,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
486,049
|
$5,929,000 | — | 31 Mar 2021 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$5,837,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.84%
|
366,100
|
$4,466,000 | — | 31 Mar 2021 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.81%
|
352,534
|
$4,385,000 | — | 31 Mar 2021 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.78%
|
337,428
|
$4,117,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.76%
|
330,694
|
$4,035,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.75%
|
323,958
|
$3,952,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.74%
|
319,119
|
$3,894,000 | — | 31 Mar 2021 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
256,000
|
$3,123,000 | — | 31 Mar 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.47%
|
202,806
|
$2,474,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.44%
|
192,667
|
$2,351,000 | — | 31 Mar 2021 | |
| Carlson Capital, L.P. |
13F
|
Company |
0.36%
|
154,600
|
$1,886,000 | — | 31 Mar 2021 | |
| P.A.W. CAPITAL CORP |
13F
|
Company |
0.32%
|
140,000
|
$1,708,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
109,980
|
$1,342,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.24%
|
102,669
|
$1,252,000 | — | 31 Mar 2021 | |
| Voss Capital, LP |
13F
|
Company |
0.23%
|
100,000
|
$1,220,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
78,376
|
$956,000 | — | 31 Mar 2021 | |
| Bleichroeder LP |
13F
|
Company |
0.17%
|
75,000
|
$915,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.17%
|
74,237
|
$906,000 | — | 31 Mar 2021 | |
| Sigma Planning Corp |
13F
|
Company |
0.17%
|
73,088
|
$892,000 | — | 31 Mar 2021 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.15%
|
65,886
|
$804,000 | — | 31 Mar 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.14%
|
59,358
|
$724,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.13%
|
58,500
|
$714,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.13%
|
56,457
|
$689,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
0.13%
|
55,400
|
$676,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
52,422
|
$640,000 | — | 31 Mar 2021 | |
| Rock Creek Group LLC |
13F
|
Company |
0.12%
|
50,000
|
$610,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.1%
|
44,437
|
$542,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.1%
|
44,311
|
$541,000 | — | 31 Mar 2021 | |
| APOGEM CAPITAL LLC |
13F
|
Company |
0.1%
|
42,702
|
$521,000 | — | 31 Mar 2021 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.09%
|
40,200
|
$490,000 | — | 31 Mar 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.09%
|
39,600
|
$483,000 | — | 31 Mar 2021 | |
| PRECEPT MANAGEMENT LLC |
13F
|
Company |
0.08%
|
35,000
|
$427,000 | — | 31 Mar 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
33,092
|
$404,000 | — | 31 Mar 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.07%
|
28,600
|
$349,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
28,490
|
$348,000 | — | 31 Mar 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.06%
|
27,430
|
$333,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.06%
|
25,400
|
$310,000 | — | 31 Mar 2021 | |
| Trexquant Investment LP |
13F
|
Company |
0.06%
|
25,334
|
$309,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
24,730
|
$302,000 | — | 31 Mar 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.05%
|
22,901
|
$280,000 | — | 31 Mar 2021 | |
| WESTWOOD HOLDINGS GROUP INC |
13F
|
Company |
0.05%
|
22,500
|
$275,000 | — | 31 Mar 2021 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2021
As of 30 Jun 2021,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,582,224 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, Corriente Advisors, LLC, Slate Path Capital LP, STATE STREET CORP, 683 Capital Management, LLC, Woodline Partners LP, Prosight Management, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
88
Q2 2021 holders
89
Holder diff
1
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.